The global albumin & creatinine tests market size is valued at an estimated USD 987 million in 2020 and is projected to reach USD 2,103 million by 2025, at a CAGR of 16.3% during the forecast period. The growth of the global albumin & creatinine tests market is driven by factors such as growing prevalence of kidney disorders, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions. However, factors like unfavorable healthcare reforms in the US and the high cost of automated analyzers are hampering the growth of the albumin & creatinine tests market during the forecasted period. The dipstick & kits segment accounted for the highest growth rate in the albumin & creatinine tests market, by product, during the forecast period “ Based on product, the albumin & creatinine tests market is segmented into dipsticks & kits, analyzers, cartridges, and reagents & other consumables.In 2019, the dipsticks & kits segment accounted for the largest share in this market.
The frequent purchase of these products compared to instruments like analyzers and cartridges and the increasing use of kit-based rapid techniques for albumin & creatinine tests drive market growth.
Urine Tests segment accounted for the highest CAGR Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests.In 2019, urine tests accounted for the largest share in this market.
Factors such as the rapid growth in the diagnostics segment and the increasing demand for rapid and easy-to-use urine tests drive the growth of this segment.
Asia Pacific: The fastest-growing region albumin & creatinine tests market The Asia Pacific albumin & creatinine tests market is estimated to grow at the highest CAGR, mainly due to the expansion of key market players in emerging Asian countries, increasing expenditure on life science and medical research in the region, and the increasing geriatric population and prevalence of chronic conditions in Asian countries such as India and China.
The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35% • By Designation: C-level - 30%, D-level - 20%, and Others - 50% • By Region: North America - 36%, Europe - 25%, Asia Pacific - 27%, Latin America – 9%, and Middle East and Africa – 3%.
List of companies profiled in the report: • Thermo Fisher Scientific, Inc. (US) • Roche Diagnostics (Switzerland) • PromoCell GmbH (Germany) • Abbott Laboratories (US) • Siemens Healthineers (Germany) • Danaher Corporation (US) • Sysmex Corporation (Japan) • Ortho Clinical Diagnostics (US) • Randox Laboratories (UK) • FUJIFILM Wako Pure Chemical Corporation (Japan) • Abbexa Ltd. (UK) • ACON Laboratories, Inc. (US) • Arbor Assays Inc. (US) • ARKRAY Global Business Inc. (Japan) • Aviva Systems Biology (US) • Axxora, LLC (UK) • BioAssay Systems (US) • Nova Biomedical (US) • Quantimetrix Corporation (US) • RayBiotech Inc. (US) • Sekisui Diagnostics PEI Inc. (US) • Teco Diagnostics (US) • Tulip Diagnostics (India) • ulti med Products GmbH (Germany) • URIT Medical Electronic Co., Ltd. (China)
Research Coverage: This report provides a detailed picture of the global albumin & creatinine tests market.It aims at estimating the size and future growth potential of the market across different segments, such as product, technique, application, end user, and region.
The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall albumin & creatinine tests market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.
This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, challenges, and trends.
Our reports have been used by over 10K customers, including:
The global in-vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6% during the forecast period. Market growth is attributed to the rising per capita income in developed and developing countries and technological advancements introduced in the in-vitro diagnostic devices. By...
The United States In Vitro Diagnostics (IVD) market is predicted to reach nearly US$ 37 Billion by 2026. In-vitro Diagnostics (IVD) serves a key role in the healthcare value chain by significantly influencing the quality of health outcomes, patient treatment, care and downstream resource requirements. With an aging population, technological...
The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9billion in 2020, at a CAGR of 16.8% during the forecast period. Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects...
198 pages •
By Asia Market Information & Development Company
• Sep 2020
China’s demand for In Vitro Diagnostics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...
94 pages •
By Asia Market Information & Development Company
• Sep 2020
This study focuses on China’s In Vitro Diagnostics industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...
The global IVD quality control market is projected to grow at a CAGR of 3.8%. The global IVD quality control market size is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period. The market for IVD quality control is primarily driven by the increasing number of accredited...
Executive Summary Global In Vitro Diagnostics Market was valued at USD 61700.22 Million in the year 2018. As size of old age population is increasing globally, quality healthcare is required. Diagnostics have major role, as majority of clinical decisions are based on diagnostic test result. They assist in providing personalised...
The India household insecticides market is accounted to US$ 1,147.5 Mn in 2018 and is expected to grow at a CAGR of 5.4% during the forecast period 2019 - 2027, to account for US$ 1,829.6 Mn by 2027. The household insecticides market has been witnessing a remarkable growth in India from the last few years. Household insecticide products are...
United States In Vitro Diagnostics (IVD) market is expected to reach US$ 33.7 Billion by 2025. United States represents the largest IVD market across the world. With an aging population, technological advances and advent of point of care diagnostics, United States IVD market is slated to show substantial growth in the future. The increase...
70 pages •
By Infiniti Research Limited
• May 2017
About In-vitro diagnostics (IVD)
IVD procedures are conducted outside of a living organism in a test tube, petri dish, or culture dish. Whereas, in vivo diagnostics are carried out inside a living organism. IVD products are intended to collect biological samples such as blood, sputum, urine, spinal fluid, and DNA from a patient's...
In Vitro Diagnostics
Point Of Care Testing
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.